Codexis, Inc. (CDXS)
1.82
-0.04
(-2.41%)
USD |
NASDAQ |
Dec 10, 16:00
1.82
0.00 (0.00%)
After-Hours: 18:35
Codexis Total Assets (Quarterly): 123.96M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| EyePoint Pharmaceuticals, Inc. | 251.70M |
| Tarsus Pharmaceuticals, Inc. | 534.56M |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 85.42M |
| Shareholders Equity (Quarterly) | 38.54M |
| Debt to Equity Ratio | 1.780 |
| Current Ratio | 4.124 |
| Net Debt Paydown Yield | -2.37% |